DUBLIN–(BUSINESS WIRE)–The “Project Management for Pharma Professionals Training Course (Mar 9th – Mar 10th, 2026)” training has been added to ResearchAndMarketsDUBLIN–(BUSINESS WIRE)–The “Project Management for Pharma Professionals Training Course (Mar 9th – Mar 10th, 2026)” training has been added to ResearchAndMarkets

2 Day Pharma Professionals Project Management Training Course (Online Event: Mar 9th – Mar 10th, 2026) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Project Management for Pharma Professionals Training Course (Mar 9th – Mar 10th, 2026)” training has been added to ResearchAndMarkets.com’s offering.

This interactive two-day course has been designed to provide you with a thorough understanding of both technical and interpersonal project management skills.

Drug and device development is a complex process which needs effective project management. With ever-increasing pressures in the industry, the use of project management can provide essential tools and techniques and be a key factor in the successful completion of bringing a drug or medical device to market – as demonstrated by the FDA critical path initiative.

Interactive exercises are used to aid the learner in the application of project management concepts and principles so they can easily use the tools to improve the success of existing or future pharmaceutical projects.

The programme will include a number of sessions where you will be able to apply some of the techniques to a simulated pharmaceutical case study as well as your own projects. You are therefore encouraged to bring a real project you are currently involved in or will be working on to which you can apply some of the concepts and techniques. There is no need to disclose any confidential information about your project.

Benefits of attending:

  • Acquire an in-depth understanding of technical project management methodologies and techniques to apply to pharma/bio projects, including agile project management
  • Learn how to incorporate these project management processes into everyday working practices and your current projects
  • Understand how to blend together both the technical aspects of project management and the essential interpersonal skills
  • Discover how to build core competencies to become an even more effective project manager
  • Discuss how to get the best results in a project team environment

Aims and objectives

The objective of this course is to ensure you gain a comprehensive understanding of the tools and techniques of project management and discover how they can be applied straight away to your own pharma/bio or medical device projects.

The programme has been specially designed to ensure that you:

  • Understand technical project management tools and techniques and can apply these to your work
  • Examine the competencies appropriate for an effective project manager
  • Identify the project critical path and use this information to assist in planning decisions
  • Gain a better understanding of the essential personal skills which are necessary to achieve project objectives

Who Should Attend:

  • This course has been specifically designed to address the needs of pharma/bio professionals as well as those in the medical device and animal health industries.
  • The programme will benefit both newly appointed and established project team leaders/managers wishing to refresh or update their skills.

Certifications:

  • CPD: 12 hours for your records
  • Certificate of completion

Key Topics Covered:

Day 1

What is a Project/Project Management in the pharma/bio industry?

  • Defining the key characteristics of project management and their importance to the bio/pharma industry
  • Using a project management process for improving the success of your own projects
  • Sharing experiences and lessons learned from previous bio/pharma projects

Setting clear project objectives and defining the scope of pharma/bio projects

  • Aligning the project objectives with the strategic and financial business objectives
  • Defining the result, the cost and the time
  • Understanding the importance of having an overall strategy for your projects

Detailed project planning of pharma/bio projects

  • Identifying the key project activities using a Work Breakdown Structure (WBS)
  • Allocate responsibilities using the responsibility matrix
  • Planning a realistic schedule using Gantt analysis and setting clear milestones
  • Budget planning, Communication plan, Quality plan
  • Implementing risk management and contingency planning for your project
  • Experiences of project management software and tracking systems

Project implementation and control for your projects

  • Identifying the possible causes of problems in pharmaceutical/bio projects
  • Effective communication and how to manage stakeholders
  • Overcoming enablers and constraints of your projects
  • Implementing project control and reporting systems
  • Monitoring project activities and performance

Day 2

Project review and closure

  • Close the project
  • Identifying the critical success factors and learning from mistakes

Pharma/bio leadership skills

  • Defining the role and skills of effective pharma project leaders
  • Improving your interpersonal skills as a leader

Motivate to achieve project milestones

  • Understand how to motivate different people and what motivates your project team
  • Completion of a self-evaluation questionnaire

Building pharma/bio project teams

  • How to modify your leadership style to get the best results in a project team environment
  • Building a high performance team

Project communication and cross-cultural communication skills

  • Effective communication and how to gain project buy-in
  • Preventing and overcoming misunderstandings and dealing with conflict
  • Communicating effectively with the project stakeholders including cross culturally

Project time management

Speakers:

Laura Brown

Pharmaceutical QA and Training Consultant

University of Cardiff

Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.

She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.

For more information about this training visit https://www.researchandmarkets.com/r/q85det

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

North America Sees $2.3T in Crypto

North America Sees $2.3T in Crypto

The post North America Sees $2.3T in Crypto appeared on BitcoinEthereumNews.com. Key Notes North America received $2.3 trillion in crypto value between July 2024 and June 2025, representing 26% of global activity. Tokenized U.S. treasuries saw assets under management (AUM) grow from $2 billion to over $7 billion in the last twelve months. U.S.-listed Bitcoin ETFs now account for over $120 billion in AUM, signaling strong institutional demand for the asset. . North America has established itself as a major center for cryptocurrency activity, with significant transaction volumes recorded over the past year. The region’s growth highlights an increasing institutional and retail interest in digital assets, particularly within the United States. According to a new report from blockchain analytics firm Chainalysis published on September 17, North America received $2.3 trillion in cryptocurrency value between July 2024 and June 2025. This volume represents 26% of all global transaction activity during that period. The report suggests this activity was influenced by a more favorable regulatory outlook and institutional trading strategies. A peak in monthly value was recorded in December 2024, when an estimated $244 billion was transferred in a single month. ETFs and Tokenization Drive Adoption The rise of spot Bitcoin BTC $115 760 24h volatility: 0.5% Market cap: $2.30 T Vol. 24h: $43.60 B ETFs has been a significant factor in the market’s expansion. U.S.-listed Bitcoin ETFs now hold over $120 billion in assets under management (AUM), making up a large portion of the roughly $180 billion held globally. The strong demand is reflected in a recent resumption of inflows, although the products are not without their detractors, with author Robert Kiyosaki calling ETFs “for losers.” The market for tokenized real-world assets also saw notable growth. While funds holding tokenized U.S. treasuries expanded their AUM from approximately $2 billion to more than $7 billion, the trend is expanding into other asset classes.…
Paylaş
BitcoinEthereumNews2025/09/18 02:07
What Happened With Bitcoin This Year? 2025 BTC Roundup

What Happened With Bitcoin This Year? 2025 BTC Roundup

Here’s how Bitcoin reached new highs this year, gained state support, saw record ETF inflows and ended with a heavy October crash. 2025 has now become a year few
Paylaş
LiveBitcoinNews2025/12/31 18:30
Fed cuts interest rates for first time in 2025

Fed cuts interest rates for first time in 2025

The Federal Reserve has followed through with its widely expected decision, cutting rates by 25 basis points and leaving the door open for more cuts. The Federal Reserve’s widely anticipated decision came on Wednesday, September 17. The Federal Open Market…
Paylaş
Crypto.news2025/09/18 02:20